Brief report of efficacy and side effect profile of crossing over to modified-release capsules of methylphenidate in ADHD patients receiving other treatments: case series

OBJECTIVES: Stimulants are recommended as the first-line pharmacotherapy in attention deficit/hyperactivity disorder (ADHD). Methylphenidate (MPH) is the most used stimulant. Medikinet Retard has modified-release capsules of MPH (MRC-MPH). In this study, we aimed to report observations on a sample of...

Полное описание

Библиографические подробности

Главные авторы:	Burcu Özbaran, Sezen Köse, Fevzi Tuna Ocakoğlu, Hakan Kayış, Ayşegül Satar, Uğur Tekin
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Mesut Çetin 2017-07-01
Серии:	Psychiatry and Clinical Psychopharmacology
Предметы:	ADHD pharmacotherapy side effects adverse effects psychopharmacology
Online-ссылка:	http://dx.doi.org/10.1080/24750573.2017.1358684
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!